ClearPoint Neuro, Inc. Share-based Payment Arrangement, Expense
ClearPoint Neuro, Inc. (CLPT) reported Share-based Payment Arrangement, Expense of $2.27 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-03
- ClearPoint Neuro, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $2.27M, a 0.09% increase year-over-year.
- ClearPoint Neuro, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $2.22M, a 16.25% increase year-over-year.
- ClearPoint Neuro, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $1.98M, a 16.32% increase year-over-year.
- ClearPoint Neuro, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $2.02M, a 6.20% increase year-over-year.
- ClearPoint Neuro, Inc. share-based payment arrangement, expense for fiscal 2025 was $8.18M, a 18.43% increase from fiscal 2024.
- ClearPoint Neuro, Inc. share-based payment arrangement, expense for fiscal 2024 was $6.91M, a 13.62% increase from fiscal 2023.
- ClearPoint Neuro, Inc. share-based payment arrangement, expense for fiscal 2023 was $6.08M, a 47.33% increase from fiscal 2022.
- ClearPoint Neuro, Inc. share-based payment arrangement, expense for fiscal 2022 was $4.13M, a 98.56% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.27M 10-Q · filed 2026-08-03 | $4.49M 10-Q · filed 2026-08-03 | $6.47M derived: sum of 3 quarters · filed 2026-08-03 | $8.49M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2026-03-31 | $2.22M 10-Q · filed 2026-05-13 | $4.20M derived: sum of 2 quarters · filed 2026-05-13 | $6.22M derived: sum of 3 quarters · filed 2026-05-13 | $8.49M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $4.00M derived: sum of 2 quarters · filed 2026-03-17 | $6.27M derived: sum of 3 quarters · filed 2026-08-03 | $8.18M 10-K · filed 2026-03-17 | |||
| 2025-09-30 | $2.02M 10-Q · filed 2025-11-06 | $4.29M derived: sum of 2 quarters · filed 2026-08-03 | $6.20M 10-Q · filed 2025-11-06 | $7.90M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-06-30 | $2.27M 10-Q · filed 2026-08-03 | $4.18M 10-Q · filed 2026-08-03 | $5.88M derived: sum of 3 quarters · filed 2026-08-03 | $7.78M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-03-31 | $1.91M 10-Q · filed 2026-05-13 | $3.61M derived: sum of 2 quarters · filed 2026-05-13 | $5.51M derived: sum of 3 quarters · filed 2026-05-13 | $7.31M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $3.61M derived: sum of 2 quarters · filed 2026-03-17 | $5.40M derived: sum of 3 quarters · filed 2026-03-17 | $6.91M 10-K · filed 2026-03-17 | |||
| 2024-09-30 | $1.90M 10-Q · filed 2025-11-06 | $3.70M derived: sum of 2 quarters · filed 2025-11-06 | $5.20M 10-Q · filed 2025-11-06 | $6.75M derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | $1.80M 10-Q · filed 2025-08-12 | $3.30M 10-Q · filed 2025-08-12 | $4.84M derived: sum of 3 quarters · filed 2025-08-12 | $6.43M derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | $1.50M 10-Q · filed 2025-05-13 | $3.05M derived: sum of 2 quarters · filed 2025-05-13 | $4.63M derived: sum of 3 quarters · filed 2025-05-13 | $6.28M derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $3.13M derived: sum of 2 quarters · filed 2025-02-26 | $4.77M derived: sum of 3 quarters · filed 2025-02-26 | $6.08M 10-K · filed 2025-02-26 | |||
| 2023-09-30 | $1.58M 10-Q · filed 2024-11-07 | $3.23M derived: sum of 2 quarters · filed 2024-11-07 | $4.54M 10-Q · filed 2024-11-07 | $5.71M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $1.65M 10-Q · filed 2024-08-07 | $2.95M 10-Q · filed 2024-08-07 | $4.12M derived: sum of 3 quarters · filed 2024-08-07 | $5.30M derived: sum of 4 quarters · filed 2024-08-07 | |||
| 2023-03-31 | $1.31M 10-Q · filed 2024-05-07 | $2.48M derived: sum of 2 quarters · filed 2024-05-07 | $3.65M derived: sum of 3 quarters · filed 2024-05-07 | $4.53M derived: sum of 4 quarters · filed 2024-05-07 | |||
| 2022-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $2.35M derived: sum of 2 quarters · filed 2024-03-12 | $3.23M derived: sum of 3 quarters · filed 2024-03-12 | $4.13M 10-K · filed 2024-03-12 | |||
| 2022-09-30 | $1.18M 10-Q · filed 2023-11-09 | $2.06M derived: sum of 2 quarters · filed 2023-11-09 | $2.95M 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | $880.00K 10-Q · filed 2023-08-08 | $1.78M 10-Q · filed 2023-08-08 | |||||
| 2022-03-31 | $899.00K 10-Q · filed 2023-05-11 | ||||||
| 2021-12-31 | $2.08M 10-K · filed 2023-03-01 | $100.00K 10-K · filed 2022-03-09 | |||||
| 2015-03-31 | $367.31K 10-Q · filed 2015-05-07 | ||||||
| 2014-09-30 | $192.00K 10-Q · filed 2014-11-14 | $376.16K derived: sum of 2 quarters · filed 2014-11-14 | $555.91K 10-Q · filed 2014-11-14 | ||||
| 2014-06-30 | $184.16K 10-Q · filed 2014-08-11 | $363.91K 10-Q · filed 2014-08-11 | |||||
| 2014-03-31 | $179.75K 10-Q · filed 2015-05-07 | ||||||
| 2013-09-30 | $345.63K 10-Q · filed 2014-11-14 | $669.76K derived: sum of 2 quarters · filed 2014-11-14 | $988.22K 10-Q · filed 2014-11-14 | ||||
| 2013-06-30 | $324.12K 10-Q · filed 2014-08-11 | $642.59K 10-Q · filed 2014-08-11 | |||||
| 2013-03-31 | $318.47K 10-Q · filed 2014-05-13 | ||||||
| 2012-09-30 | $300.30K 10-Q · filed 2013-11-13 | $299.08K 10-Q · filed 2012-11-14 | $614.01K derived: sum of 2 quarters · filed 2013-11-13 | $843.87K 10-Q · filed 2013-11-13 | $842.64K 10-Q · filed 2012-11-14 | ||
| 2012-06-30 | $313.71K 10-Q · filed 2013-08-14 | $543.56K 10-Q · filed 2013-08-14 | |||||
| 2011-09-30 | $248.54K 10-Q · filed 2012-11-14 | $502.46K derived: sum of 2 quarters · filed 2012-11-14 | $757.20K 10-Q · filed 2012-11-14 | ||||
| 2011-06-30 | $253.92K 10-Q · filed 2012-08-14 | $508.66K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |